Arrepath

Developer of anti-infectives to address antimicrobial resistance (AMR)

placePrinceton, New Jersey, United States calendar_todayFounded 2021 groups16 employees language arrepath.com

Innovation

5 patent families — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace active. Cited 39 times.

YearFilings
20254
20261

Social engagement

Social engagement: 1.5K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Boehringer Ingelheim Venture Fund, Insight Partners, Innospark Ventures.

Investor typeCountShare
Venture capital758%
Private equity217%
Bank & private debt18%
Other / undisclosed217%

Recent activity

1 Apr 2026
Event
CAN-AMR-Net Antibiotic Drug Discovery: From AIEnabled Discovery to Successful Commercialization training
26 Sep 2025
Event
2025 World Medical Innovation Forum
25 Sep 2025
Event
Global AMR Innovators Conference (GAMRIC)
Coming soon